ZA200809565B - 4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancer - Google Patents
4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancerInfo
- Publication number
- ZA200809565B ZA200809565B ZA200809565A ZA200809565A ZA200809565B ZA 200809565 B ZA200809565 B ZA 200809565B ZA 200809565 A ZA200809565 A ZA 200809565A ZA 200809565 A ZA200809565 A ZA 200809565A ZA 200809565 B ZA200809565 B ZA 200809565B
- Authority
- ZA
- South Africa
- Prior art keywords
- methanesulphonyl
- benzoylamino
- piperidin
- pyrazole
- dichloro
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74654106P | 2006-05-05 | 2006-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200809565B true ZA200809565B (en) | 2009-09-30 |
Family
ID=40880920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200809565A ZA200809565B (en) | 2006-05-05 | 2008-11-10 | 4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancer |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101484439A (en) |
ZA (1) | ZA200809565B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105616419A (en) * | 2014-11-07 | 2016-06-01 | 江苏豪森药业集团有限公司 | Pharmaceutical composition containing cyclin inhibitor solid dispersion, and preparation method thereof |
CN107235906B (en) * | 2017-06-28 | 2020-05-01 | 郑州大学第一附属医院 | Pyrazole amide derivatives and application thereof |
CN109705090B (en) * | 2017-10-25 | 2023-06-20 | 上海君实生物医药科技股份有限公司 | Tartaric acid addition salts of 3, 4-disubstituted 1H-pyrazole compounds and crystalline forms thereof |
GB202015187D0 (en) * | 2020-09-25 | 2020-11-11 | Sentinel Oncology Ltd | A pharmaceutical salt |
-
2007
- 2007-05-04 CN CNA2007800252778A patent/CN101484439A/en active Pending
-
2008
- 2008-11-10 ZA ZA200809565A patent/ZA200809565B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101484439A (en) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2870A (en) | Odcase inhibitors for the treatment of malaria | |
ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
IL187168A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
EP1976377A4 (en) | Compounds for the treatment of metabolic disorders | |
HK1127489A1 (en) | Pyridiazinone derivatives for the treatment of tumours | |
IL192241A (en) | Process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof | |
EP1983972A4 (en) | Compounds for the treatment of metabolic disorders | |
IL192242A0 (en) | Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides | |
IL195203A0 (en) | Compounds for the treatment of metabolic disorders | |
PT2056814E (en) | 2,5-dihydroxybenzene compounds for the treatment of psoriasis | |
IL190920A0 (en) | Compounds for the treatment of metabolic disorders | |
AP2886A (en) | 6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders | |
IL192852A0 (en) | Compounds for the treatment of metabolic disorders | |
ME01609B (en) | Roflumilast for the treatment of pulmonary hypertension | |
ZA200809565B (en) | 4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancer | |
IL199239A0 (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6- | |
IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
EP2231558A4 (en) | 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease | |
IL192982A0 (en) | Compounds for the treatment of metabolic disorders | |
GB0705674D0 (en) | Composition for the treatment of halitosis | |
IL208127A0 (en) | Ptph1 inhibitors for the treatment of alzheimer's disease |